The use of antibacterial medicine in France has experienced fluctuations over the past decade. From 2013 to 2016, the variation was generally minimal with minor up and down trends. However, substantial changes occurred thereafter, notably in 2020 when usage dropped significantly by 19.12% due to potential factors like increased awareness around antibacterial resistance or alternate medical advisements. Recovery was observed in the subsequent years, with a notable rise of 11.63% in 2022. By 2023, the value stood at 24.8 DDD per thousand persons per day, marking a 3.33% increase year-on-year.
The outlook from 2024 to 2028 suggests a steady decline with a forecasted CAGR of -0.33%. This continuing decrease, with a cumulative reduction of 1.62% over this period, indicates a measured control and possibly tighter regulations on antibacterial medicine usage.
Future trends to watch for include new policies on antibiotic stewardship, the impact of public health campaigns promoting responsible use, and advancements in alternative treatments which may further reduce reliance on traditional antibacterial medicines.
